SenesTech Stock Forecast, Price & News

-0.04 (-2.45 %)
(As of 06/18/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume144,535 shs
Average Volume1.36 million shs
Market Capitalization$19.37 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SNES News and Ratings via Email

Sign-up to receive the latest news and ratings for SenesTech and its competitors with MarketBeat's FREE daily newsletter.

SenesTech logo

About SenesTech

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait that limits reproduction of male and female rats. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.33 out of 5 stars

Medical Sector

839th out of 2,097 stocks

Agricultural Chemicals Industry

9th out of 21 stocks

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

SenesTech (NASDAQ:SNES) Frequently Asked Questions

Is SenesTech a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for SenesTech in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" SenesTech stock.
View analyst ratings for SenesTech
or view top-rated stocks.

What stocks does MarketBeat like better than SenesTech?

Wall Street analysts have given SenesTech a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but SenesTech wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting SenesTech?

SenesTech saw a decrease in short interest in May. As of May 28th, there was short interest totaling 250,000 shares, a decrease of 22.4% from the May 13th total of 322,100 shares. Based on an average trading volume of 1,750,000 shares, the short-interest ratio is presently 0.1 days. Approximately 2.5% of the shares of the stock are sold short.
View SenesTech's Short Interest

When is SenesTech's next earnings date?

SenesTech is scheduled to release its next quarterly earnings announcement on Wednesday, August 11th 2021.
View our earnings forecast for SenesTech

How were SenesTech's earnings last quarter?

SenesTech, Inc. (NASDAQ:SNES) announced its quarterly earnings results on Thursday, May, 13th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.16) by $0.06. The business earned $0.09 million during the quarter, compared to analysts' expectations of $0.08 million. SenesTech had a negative net margin of 2,241.14% and a negative trailing twelve-month return on equity of 107.54%.
View SenesTech's earnings history

How has SenesTech's stock price been impacted by COVID-19?

SenesTech's stock was trading at $2.48 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SNES shares have decreased by 35.9% and is now trading at $1.59.
View which stocks have been most impacted by COVID-19

When did SenesTech's stock split? How did SenesTech's stock split work?

SenesTech shares reverse split before market open on Wednesday, February 5th 2020. The 1-20 reverse split was announced on Tuesday, February 4th 2020. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 4th 2020. An investor that had 100 shares of SenesTech stock prior to the reverse split would have 5 shares after the split.

What price target have analysts set for SNES?

1 brokers have issued 12 month target prices for SenesTech's shares. Their forecasts range from $4.00 to $4.00. On average, they expect SenesTech's share price to reach $4.00 in the next year. This suggests a possible upside of 151.6% from the stock's current price.
View analysts' price targets for SenesTech
or view top-rated stocks among Wall Street analysts.

Who are SenesTech's key executives?

SenesTech's management team includes the following people:
  • Mr. Kenneth S. Siegel, CEO & Director (Age 65, Pay $296.25k)
  • Mr. Thomas C. Chesterman, Exec. VP, CFO, Treasurer & Assistant Sec. (Age 62, Pay $246.32k)
  • Ms. Kim Patrice Wolin, Exec. VP of Operations & Sec. (Age 66, Pay $90.84k)
  • Dr. Steven C. Krause Ph.D., Exec. VP of Sales & Marketing (Age 61, Pay $240.33k)
  • Mr. Paul M. Palz, VP & Corp. Controller

Who are some of SenesTech's key competitors?

What other stocks do shareholders of SenesTech own?

When did SenesTech IPO?

(SNES) raised $15 million in an IPO on Thursday, December 8th 2016. The company issued 1,900,000 shares at $8.00 per share. Roth Capital Partners acted as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager.

What is SenesTech's stock symbol?

SenesTech trades on the NASDAQ under the ticker symbol "SNES."

Who are SenesTech's major shareholders?

SenesTech's stock is owned by a variety of institutional and retail investors. Top institutional investors include Virtu Financial LLC (0.89%), Sheaff Brock Investment Advisors LLC (0.87%), Bank of New York Mellon Corp (0.66%) and Dimensional Fund Advisors LP (0.56%). Company insiders that own SenesTech stock include Cheryl Ann Dyer, Kenneth S Siegel and Loretta Powers Mayer.
View institutional ownership trends for SenesTech

Which institutional investors are buying SenesTech stock?

SNES stock was purchased by a variety of institutional investors in the last quarter, including Virtu Financial LLC, Sheaff Brock Investment Advisors LLC, Bank of New York Mellon Corp, and Dimensional Fund Advisors LP.
View insider buying and selling activity for SenesTech
or or view top insider-buying stocks.

How do I buy shares of SenesTech?

Shares of SNES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SenesTech's stock price today?

One share of SNES stock can currently be purchased for approximately $1.59.

How much money does SenesTech make?

SenesTech has a market capitalization of $19.37 million and generates $280,000.00 in revenue each year. The company earns $-7,940,000.00 in net income (profit) each year or ($2.78) on an earnings per share basis.

How many employees does SenesTech have?

SenesTech employs 29 workers across the globe.

What is SenesTech's official website?

The official website for SenesTech is

Where are SenesTech's headquarters?

SenesTech is headquartered at 23460 NORTH 19TH AVENUE SUITE 110, PHOENIX AZ, 85027.

How can I contact SenesTech?

SenesTech's mailing address is 23460 NORTH 19TH AVENUE SUITE 110, PHOENIX AZ, 85027. The company can be reached via phone at (928) 779-4143 or via email at [email protected]

This page was last updated on 6/20/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.